INTRODUCTION: @entity2013 are @entity977 that express and secrete prolactin. These @entity1 are overweight and the mechanisms are being studied. GOALS: assess nutritional and metabolic status of overweight @entity1 with and without @entity4089 caused by @entity2013 and compare them. MATERIALS AND METHODS: cross-sectional study, @entity1 with body mass index (BMI) >=  25 kg/m2 with and without @entity2013 : 1) 20 normoprolactinemic (NPrl) with @entity2013 ; 2) 23 hyperprolactinemic (HPrl) with @entity2013 ; 3) 28 controls without @entity2013 or alterations in prolactin levels. Evaluated through anthropometric, dietetics, and biochemical assessment. RESULTS: of the 71 @entity1 evaluated, most were @entity28 @entity1 with @entity2013 . All three groups had diets with low caloric and @entity8981 ( @entity8981 ) intake, the NPrl group had low @entity1735 ( @entity435 ) intake and high @entity14391 ( @entity14391 ) and @entity10194 ( @entity10194 ) intake, and the NPrl and HPrl groups had appropriate intake of @entity1474 ( @entity5204 ). The HPrl group had elevated total @entity165 . HDL @entity165 was below the recommended threshold for most @entity1 . No statistically significant differences were found in anthropometric and biochemical variables among the groups. CONCLUSIONS: most @entity1 with @entity2013 and controls are @entity28 and metabolically similar regardless of prolactin levels. All groups presented low caloric and @entity8981 intake. Protein, @entity14391 , @entity10194 , and @entity165 were significantly different among the groups, the NPrl group ingested less amount of protein and greater of fat. Snacking between meals and changes of food consumption on weekends was reported by most @entity1 . This is the first study comparing @entity1 with @entity2013 and controls, both with overweight, regarding food consumption and feeding behavior.

NUTRITIONAL AND METABOLIC ASSESSMENT IN OVERWEIGHT XXXX WITH AND WITHOUT HYPERPROLACTINEMIA CAUSED BY PROLACTINOMA.

@entity1 :: ('9606', 'Species') :: ['women', 'patients'] @entity4089 :: ('MESH:D006966', 'Disease') :: ['hyperprolactinemia'] @entity5204 :: ('CHEBI:26208', 'Chemical') :: ['PUFA'] @entity2013 :: ('MESH:D015175', 'Disease') :: ['prolactinoma', 'prolactinomas', 'macroprolactinomas'] @entity28 :: ('MESH:D009765', 'Disease') :: ['obese'] @entity1735 :: ('CHEBI:16646', 'Chemical') :: ['carbohydrate'] @entity1474 :: ('MESH:D005231', 'Chemical') :: ['polyunsaturated fatty acids'] @entity10194 :: ('CHEBI:26607', 'Chemical') :: ['saturated fatty acid', 'SFA'] @entity977 :: ('MESH:D010911', 'Disease') :: ['pituitary adenomas'] @entity14391 :: ('MESH:D011017', 'Disease') :: ['lipid', 'LIP'] @entity8981 :: ('CHEBI:25413', 'Chemical') :: ['MUFA', 'monounsaturated fatty acid'] @entity435 :: ('CHEBI:42485', 'Chemical') :: ['CHO'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol']
@entity1 :: (9606,Species) :: ['PATIENTS']
